Ogasawara, Kazuyoshi http://orcid.org/0000-0003-2911-0708
Nakamura, Yukako
Kimura, Hiroyuki
Aleksic, Branko
Ozaki, Norio
Funding for this research was provided by:
Japan Agency for Medical Research and Development (Research, Development Grants for Comprehensive Research for Persons with Disabilities)
Article History
Received: 23 August 2017
Accepted: 12 December 2017
First Online: 23 December 2017
Compliance with ethical standards
:
: KO has received personal fees from Sumitomo Dainippon Pharma. HK has received personal fees from Pfizer. NO has received grants from Eisai, MSD, Otsuka, Dainippon Sumitomo, Takeda, Tsumura, The KAITEKI Institute, Eli Lilly, Nihon Medi-Physics, Novartis, Pfizer, personal fees from Astellas, MSD, Otsuka, Ono, Glaxo Smith Kline, Takeda, Mitsubishi Tanabe Pharma, Dainippon Sumitomo Pharma, Novartis, Eli Lilly, Pfizer, Meiji Seika, Mochida, Janssen, Yoshitomi. (These all are outside of the submitted work). YN and BA has nothing to disclose.